Mesoblast Ltd 20-F for FY2020

Headline figures

Fiscal year ended June 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue

$32.16M

up 92.3% from $16.72M a year earlier

Net loss

$77.94M

compared with a net loss of $89.8M a year earlier

Diluted EPS

-$0.15

compared with -$0.18 a year earlier